The safety of synthetic paclitaxel by intralesional delivery with OncoGel™ into skin breast cancer metastases: method and results of a clinical pilot trial
Authors:
- 29 November 2005
- journal article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- p. 1
Abstract
Ahead of Print article withdrawn by publisherKeywords
This publication has 15 references indexed in Scilit:
- A randomized phase II study of paclitaxel with carboplatin ± amifostine as first line treatment in advanced ovarian carcinomaGynecologic Oncology, 2005
- Intravenous and Regional Paclitaxel FormulationsCurrent Medicinal Chemistry, 2004
- Enhancement of paclitaxel production by temperature shift in suspension culture of Taxus chinensisEnzyme and Microbial Technology, 2000
- Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12Cancer Gene Therapy, 1999
- INJECTABLE MODALITIES AS LOCAL AND REGIONAL STRATEGIES FOR HEAD AND NECK CANCERHematology/Oncology Clinics of North America, 1999
- Local Secretion of IFN-γ Induces an Antitumor ResponseJournal of Immunotherapy, 1999
- Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomasThe Lancet, 1995
- Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brainJournal of Neurosurgery, 1994
- Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.Proceedings of the National Academy of Sciences, 1993
- Using toxicity grades in the design and analysis of cancer phase i clinical trialsStatistics in Medicine, 1992